title: Red blood cell alloimmunization in sickle cell disease: listen to your ancestors.
abstract: Red blood cell (RBC) alloimmunization occurs in approximately 30% of transfused sickle cell disease patients compared to 2-5% of all transfusion recipients. Because RBC transfusion is an important part of therapy in sickle cell disease, the need for additional antigen matching once alloimmunization occurs is problematic and leads to therapeutic limitations. Thus, identification of risk factors would benefit this patient population. Genome-wide analyses, in particular, methods which take into account genetic ancestry such as admixture mapping, could identify molecular markers which could be used to identify immune responders to transfusion.
authors: Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
authors: Sally A
authors: SA
authors: Campbell-Lee
authors: Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
authors: Rick A
authors: RA
authors: Kittles
keywords: Alloimmunization; Ancestry; Genome; Sickle cell disease; Transfusion